{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-mass-vaccination-trial-logistics-multi-site”
},
“headline”: “SOP for Mass-Vaccination Trial Logistics (Multi-Site)”,
“description”: “This SOP defines standardized procedures for planning, coordination, and execution of mass-vaccination trial logistics across multiple sites. It ensures compliance with FDA, EMA, CDSCO, WHO, and ICH GCP guidelines, covering cold chain management, shipment validation, accountability, and multi-site coordination.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Mass-Vaccination Trial Logistics (Multi-Site)

Purpose

The purpose of this SOP is to define standardized procedures for logistics planning and execution in multi-site mass-vaccination trials. It ensures that investigational vaccines are distributed, stored, and administered under validated conditions, maintaining compliance with global regulatory guidelines and safeguarding subject safety.

Scope

This SOP applies to sponsors, CROs, investigators, site pharmacists, couriers, and logistics vendors involved in multi-site vaccine trials. It covers supply chain planning, shipment validation, cold-chain management, accountability, coordination between multiple sites, and inspection readiness.

Responsibilities

• Sponsor: Oversees supply chain planning and ensures validated logistics systems.
• Investigator: Ensures site-level receipt, storage, and accountability of vaccines.
• Logistics Vendor/Courier: Ensures validated transport conditions and documentation.
• CRO: Monitors site compliance with logistics and distribution requirements.
• Site Staff: Maintain records of receipt, storage, and administration of vaccines.
• QA: Reviews logistics records and audits vendors/sites for compliance.

Accountability

The Sponsor’s Clinical Supply Chain Manager is accountable for ensuring validated logistics processes across all participating sites. Site Investigators are accountable for site-level vaccine accountability and storage compliance.

Procedure

1. Supply Chain Planning
1.1 Develop a logistics plan for multi-site vaccine distribution.
1.2 Define site allocation, shipment schedules, and buffer stocks.
1.3 Document in Supply Chain Planning Log (Annexure-1).

2. Shipment Validation
2.1 Validate shippers with temperature monitoring devices.
2.2 Ensure SOP-driven courier training.
2.3 Record details in Shipment Validation Log (Annexure-2).

3. Vaccine Receipt
3.1 Verify shipment integrity and temperature compliance.
3.2 Document in Vaccine Receipt Log (Annexure-3).

4. Cold-Chain Management
4.1 Store vaccines in validated cold storage (+2°C to +8°C or as specified).
4.2 Document daily temperatures in Cold-Chain Monitoring Log (Annexure-4).

5. Site Coordination
5.1 Ensure real-time communication between sponsor, CRO, and site teams.
5.2 Record updates in Site Coordination Log (Annexure-5).

6. Accountability
6.1 Reconcile doses received, administered, returned, or destroyed.
6.2 Record in Vaccine Accountability Log (Annexure-6).

7. Deviation Management
7.1 Record all deviations (e.g., delays, temperature excursions).
7.2 Document corrective actions in Deviation Log (Annexure-7).

8. Archiving
8.1 Archive all multi-site logistics records in TMF and ISF.
8.2 Retain per regulatory timelines (min. 15–25 years).

Abbreviations

• SOP: Standard Operating Procedure
• CRO: Contract Research Organization
• QA: Quality Assurance
• IP: Investigational Product
• TMF: Trial Master File
• ISF: Investigator Site File
• GCP: Good Clinical Practice
• FDA: Food and Drug Administration
• EMA: European Medicines Agency
• CDSCO: Central Drugs Standard Control Organization
• WHO: World Health Organization

Documents

1. Supply Chain Planning Log (Annexure-1)
2. Shipment Validation Log (Annexure-2)
3. Vaccine Receipt Log (Annexure-3)
4. Cold-Chain Monitoring Log (Annexure-4)
5. Site Coordination Log (Annexure-5)
6. Vaccine Accountability Log (Annexure-6)
7. Deviation Log (Annexure-7)

References

• FDA – Vaccine Clinical Trial Guidance
• EMA – Multi-Site Vaccine Trial Guidelines
• CDSCO – Vaccine Logistics in Trials
• ICH GCP – Vaccine Distribution Compliance
• WHO – Mass Vaccination Trial Recommendations

Version: 1.0

Approval Section

Annexures

Annexure-1: Supply Chain Planning Log

Annexure-2: Shipment Validation Log

Annexure-3: Vaccine Receipt Log

Annexure-4: Cold-Chain Monitoring Log

Annexure-5: Site Coordination Log

Annexure-6: Vaccine Accountability Log

Annexure-7: Deviation Log

Revision History

For more SOPs visit: Pharma SOP